口服MMI后KClO4释放试验对甲状腺功能的评价

EVALUATION OF KClO 4 RELEASE EXPERIMENT OF POSTADMINISTRATION MMI FOR THYROID FUNCTION

应用口服他巴唑（ＭＭＩ）后ＫＣｌＯ４释放试验方法，观察甲状腺机能亢进患者治疗后的甲状腺功能。结果表明，４５例受试者中３８例ＫＣｌＯ４释放率＜１０％（正常），７例ＫＣｌＯ４释放率＞１０％。４５例中的１７例同时做了甲状腺抑制试验，其结果与ＫＣｌＯ４释放试验有较好的符合率，说明该方法对判断甲亢治疗后的甲状腺功能有一定价值。

By means of KClO 4 release experiment postadministration MMI (methimazolum) , the thyroid function after hyperthyroidism treatment is observed. The result of 45 cases show that the release rate is less than 10% (normal value) in 38 cases and more than 10% in 7 cases. Thyroid suppression test is also performed in 17 of the 45 cases simultaneously. There is a good correspondency between the results of KClO 4 release experiment and suppression test. This method is available for the evaluation of thyroid function after hyperthyroidism treatment.